Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Cipher completes patient enrollment in phase III CIP-Isotretinoin study

Nov. 3, 2010

Briakinumab is superior to methotrexate and etanercept in treating psoriasis

Oct. 27, 2010

IL-17A-targeted antibody AIN-457 shows promise in psoriasis, rheumatoid arthritis and uveitis

Oct. 26, 2010

Cardium Therapeutics reports new findings on Excellagen in wound healing

Oct. 26, 2010

Tasocitinib meets primary endpoint in phase II psoriasis trial

Oct. 11, 2010

Cosmo Pharma's CB-03-01 effective in proof-of-concept alopecia study

Oct. 7, 2010

SUN-13834 is efficacious in patients with atopic dermatitis

Sep. 29, 2010

E-6005 improves pruritus and inflammation in preclinical tests

Sep. 28, 2010

Signum Biosciences receives NIH grants for skin disorders

Sep. 22, 2010

Galderma discloses new ACAT-1 inhibitors

Sep. 20, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...